PDS Biotechnology Corp (PDSB)
3.58
+0.04
(+1.27%)
USD |
NASDAQ |
May 15, 14:41
PDS Biotechnology 1 Year Total Returns (Daily): -45.19% for May 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 14, 2024 | -45.19% |
May 13, 2024 | -44.34% |
May 10, 2024 | -48.68% |
May 09, 2024 | -44.25% |
May 08, 2024 | -40.36% |
May 07, 2024 | -42.19% |
May 06, 2024 | -42.88% |
May 03, 2024 | -39.17% |
May 02, 2024 | -36.99% |
May 01, 2024 | -40.82% |
April 30, 2024 | -44.90% |
April 29, 2024 | -44.24% |
April 26, 2024 | -44.76% |
April 25, 2024 | -46.91% |
April 24, 2024 | -48.66% |
April 23, 2024 | -51.44% |
April 22, 2024 | -54.63% |
April 19, 2024 | -59.92% |
April 18, 2024 | -57.85% |
April 17, 2024 | -60.23% |
April 16, 2024 | -59.36% |
April 15, 2024 | -59.07% |
April 12, 2024 | -49.41% |
April 11, 2024 | -45.99% |
April 10, 2024 | -47.06% |
Date | Value |
---|---|
April 09, 2024 | -43.72% |
April 08, 2024 | -43.03% |
April 05, 2024 | -41.38% |
April 04, 2024 | -42.68% |
April 03, 2024 | -39.27% |
April 02, 2024 | -39.51% |
April 01, 2024 | -34.63% |
March 28, 2024 | -32.31% |
March 27, 2024 | -32.22% |
March 26, 2024 | -23.02% |
March 25, 2024 | -18.73% |
March 22, 2024 | -20.89% |
March 21, 2024 | -22.42% |
March 20, 2024 | -22.04% |
March 19, 2024 | -25.20% |
March 18, 2024 | -24.16% |
March 15, 2024 | -26.09% |
March 14, 2024 | -31.64% |
March 13, 2024 | -30.15% |
March 12, 2024 | -28.29% |
March 11, 2024 | -23.10% |
March 08, 2024 | -22.77% |
March 07, 2024 | -18.03% |
March 06, 2024 | -14.57% |
March 05, 2024 | -20.44% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.26%
Minimum
Mar 17 2020
916.6%
Maximum
Jun 14 2021
58.12%
Average
-20.89%
Median
Mar 22 2024
1 Year Total Returns (Daily) Benchmarks
Syros Pharmaceuticals Inc | 56.94% |
PAVmed Inc | -71.71% |
Altimmune Inc | 53.63% |
Regeneron Pharmaceuticals Inc | 32.28% |
iBio Inc | -90.69% |